EUVIMEDEUVIMED entdecken
Open Access

Podocan‐Like Protein 1 as a Novel Contributor to HIV‐Associated Pulmonary Vascular Disease

Laszlo Kovacs iD, Taylor C Kress iD, Anita Kovacs-Kasa iD, Robin Brice, Sakshi Vanjani, Rodger MacArthur, Coleton R Jordan iD, Simone Kennard, Eric J Belin de Chantemele iD

Journal of the American Heart Association · 01.09.2026 · 15 (17)

DOI: 10.1161/jaha.125.048816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 01.09.2026. Verfasst von Laszlo Kovacs und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, & Sleep Medicine, Department of Medicine Medical College of Georgia, Augusta University Augusta GA USA. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thanks to the advent of combination antiretroviral therapy, life expectancy has noticeably increased in people with HIV; however, they also display an elevated susceptibility to developing severe pulmonary vascular disease. Despite efforts to understand the role of HIV‐encoded proteins in the pathogenesis of the disease, the underlying mechanisms remain to be elucidated.

Methods

Using 3 mouse models of HIV and in vitro cell studies, we tested the hypothesis that HIV‐related proteins induce pulmonary vascular disease via Podnl1 (podocan‐like protein 1)‐dependent mechanisms.

Results

We reported that the expression of HIV proteins in Tg26 mice and bone marrow transplant from Tg26 to wild‐type mice promotes the development of pulmonary vascular disease with no sex differences. RNAseq and quantitative polymerase chain reaction analysis revealed, for the first time, high expression of Podnl1 in the lungs of our HIV models. Strikingly, lung specimens from people with HIV on combination antiretroviral therapy exhibit higher Podnl1 levels compared with individuals without HIV. We also revealed that the observed cardiopulmonary alterations and expression levels of Podnl1 were more pronounced in aged intact Tg26 mice. In addition, Podnl1 overexpression resulted in increased collagen‐I production and pulmonary artery smooth muscle cells proliferation. Remarkably, we found that HIV‐Tat (transactivator of transcription) is the only viral protein detectable in peripheral blood mononuclear cells obtained from people with HIV on combination antiretroviral therapy, and chronic exposure of mice to HIV‐Tat recapitulated the cardiopulmonary complications of intact and bone marrow transplant Tg26 mice.

Conclusions

We provide the first evidence that HIV‐Tat and Podnl1 are important contributing factors to pulmonary vascular disease related to HIV infection, which presents potential new therapeutic avenues for the prevention of HIV‐associated cardiopulmonary complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnimalsHumansDisease Models, AnimalMaleFemaleMicePulmonary ArteryMice, Inbred C57BLCell ProliferationCells, CulturedMyocytes, Smooth Muscle

Stichwörter der Autor:innen

HIVPodnl1pulmonary vascular diseaseviral proteins

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care, & Sleep Medicine, Department of Medicine Medical College of Georgia, Augusta University Augusta GA USA.
  • Vascular Biology Center Medical College of Georgia, Augusta University Augusta GA USA.
  • Division of Infectious Diseases, Department of Medicine Medical College of Georgia, Augusta University Augusta GA USA.
  • Division of Cardiology, Department of Medicine Medical College of Georgia, Augusta University Augusta GA USA.

ORCID-Profile: Laszlo Kovacs, Taylor C Kress, Anita Kovacs-Kasa, Coleton R Jordan, Eric J Belin de Chantemele

Förderung

  • NIAMS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Kovacs, L., Kress, T. C., Kovacs-Kasa, A., Brice, R., Vanjani, S., MacArthur, R., Jordan, C. R., Kennard, S., & Belin de Chantemele, E. J. (2026). Podocan‐Like Protein 1 as a Novel Contributor to HIV‐Associated Pulmonary Vascular Disease. Journal of the American Heart Association, 15(17). https://doi.org/10.1161/jaha.125.048816

Vancouver

Kovacs L, Kress TC, Kovacs-Kasa A, Brice R, Vanjani S, MacArthur R, et al. Podocan‐Like Protein 1 as a Novel Contributor to HIV‐Associated Pulmonary Vascular Disease. Journal of the American Heart Association. 2026;15(17). doi:10.1161/jaha.125.048816

BibTeX
@article{Kovacs2026,
  author = {Kovacs, Laszlo and Kress, Taylor C and Kovacs-Kasa, Anita and Brice, Robin and Vanjani, Sakshi and MacArthur, Rodger and Jordan, Coleton R and Kennard, Simone and Belin de Chantemele, Eric J},
  title = {Podocan‐Like Protein 1 as a Novel Contributor to HIV‐Associated Pulmonary Vascular Disease},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {17},
  doi = {10.1161/jaha.125.048816}
}
Kostenlos starten →